| Medical and Health Sciences | Lifetime | 210 | GB 24 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 40 | GB 4 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 8 | GB 3 | 99.96 |
| Medical Physiology | Lifetime | 252 | GB 27 | 99.60 |
| Surgery | Lifetime | 641 | GB 47 | 99.40 |
| Epidemiology | Lifetime | 699 | GB 61 | 99.09 |
| Public, Environmental and Occupational Health | Lifetime | 791 | GB 86 | 98.88 |
| Cardiology and Cardiovascular Medicine | Lifetime | 602 | GB 40 | 98.98 |
| Clinical Pharmacology | Lifetime | 587 | GB 56 | 97.48 |
| Pharmacy | Lifetime | 270 | GB 25 | 96.65 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 8 | GB 2 | 99.96 |
| Medical Physiology | 2021-2025 | 39 | GB 5 | 99.45 |
| Clinical Pharmacology | 2021-2025 | 27 | GB 2 | 98.74 |
| Molecular Biology | 2021-2025 | 471 | GB 14 | 97.61 |
| Epidemiology | 2021-2025 | 361 | GB 33 | 97.06 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 315 | GB 19 | 97.04 |
| Public, Environmental and Occupational Health | 2021-2025 | 600 | GB 61 | 94.31 |
| General Health Professions | 2021-2025 | 845 | GB 110 | 93.03 |
| Diabetes Management and Research | Lifetime | 4 | GB 2 | 99.93 |
| Chronic Disease Management Strategies | Lifetime | 4 | GB 2 | 99.84 |
| Diabetes Management and Education | Lifetime | 4 | GB 2 | 99.89 |
| Diabetes Treatment and Management | Lifetime | 7 | GB 2 | 99.92 |
| Metabolism, Diabetes, and Cancer | Lifetime | 13 | GB 1 | 99.87 |
| Pharmacology and Obesity Treatment | Lifetime | 7 | GB 2 | 99.82 |
| Diet and metabolism studies | Lifetime | 117 | GB 12 | 99.69 |
| Pancreatic function and diabetes | Lifetime | 92 | GB 13 | 99.60 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 76 | GB 10 | 99.63 |
| Physical Activity and Health | Lifetime | 70 | GB 7 | 99.38 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 59 | GB 11 | 98.94 |
| Diabetes and associated disorders | Lifetime | 228 | GB 25 | 98.90 |
| Obesity and Health Practices | Lifetime | 122 | GB 20 | 98.46 |
| Obesity, Physical Activity, Diet | Lifetime | 477 | GB 70 | 98.85 |
| Cardiovascular Function and Risk Factors | Lifetime | 683 | GB 47 | 98.82 |
| Mobile Health and mHealth Applications | Lifetime | 183 | GB 22 | 97.84 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 163 | GB 38 | 96.58 |
| Health and Lifestyle Studies | Lifetime | 549 | GB 25 | 96.06 |
| Heart Failure Treatment and Management | Lifetime | 918 | GB 61 | 96.96 |
| Dietary Effects on Health | Lifetime | 301 | GB 33 | 94.67 |
| Bariatric Surgery and Outcomes | Lifetime | 689 | GB 43 | 94.66 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 2 | GB 1 | 99.94 |
| Chronic Disease Management Strategies | 2021-2025 | 4 | GB 4 | 99.54 |
| Diabetes Treatment and Management | 2021-2025 | 9 | GB 2 | 99.93 |
| Diet and metabolism studies | 2021-2025 | 21 | GB 1 | 99.52 |
| Pharmacology and Obesity Treatment | 2021-2025 | 2 | GB 1 | 99.79 |
| Diabetes Management and Education | 2021-2025 | 5 | GB 3 | 99.51 |
| Diabetes Management and Research | 2021-2025 | 24 | GB 2 | 99.54 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 121 | GB 10 | 99.16 |
| Heart Failure Treatment and Management | 2021-2025 | 101 | GB 11 | 98.81 |
| Obesity, Physical Activity, Diet | 2021-2025 | 366 | GB 44 | 96.22 |
| Physical Activity and Health | 2021-2025 | 209 | GB 29 | 95.30 |
| Pancreatic function and diabetes | 2021-2025 | 458 | GB 51 | 92.66 |
| Cardiovascular and exercise physiology | 2021-2025 | 599 | GB 46 | 89.95 |
| Sleep and related disorders | 2021-2025 | 893 | GB 40 | 87.53 |
| Mobile Health and mHealth Applications | 2021-2025 | 768 | GB 58 | 85.26 |
| Obesity and Health Practices | 2021-2025 | 342 | GB 59 | 84.09 |
| Health and Lifestyle Studies | 2021-2025 | 682 | GB 13 | 79.58 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 661 | GB 64 | 67.47 |
| Ergonomics and Musculoskeletal Disorders | 2021-2025 | 904 | GB 32 | 59.48 |
